TrialSpark in the news.

Learn more about TrialSpark through our latest press clippings and more.

TrialSpark's mission is to new bring treatments to patients faster and more efficiently by reimagining the clinical trial process. Follow us @TrialSpark. For media inquiries, please contact our press team.

TrialSpark in the news.

TrialSpark announces partnership with major pharmaceutical company to jointly acquire and develop clinical-stage novel therapies

Development of at-home sample collection logistics for large-scale seroprevalence studies

Aditum Bio Announces Formation of Ancora Bio, to Focus on Treatment-Resistant Depression

INVEST Precision Medicine Pitch Perfect winner spotlight: TrialSpark

Aditum Bio, New Company Co-Founded by Novartis Veterans Joe Jimenez and Dr. Mark Fishman

Continuity of Care in Clinical Trials During a Pandemic: Protecting Safety and Promoting Data Integrity

Clinical trials must think outside, and inside the box

TrialSpark announces collaboration with Limbix on conducting an end-to-end clinical trial on Limbix's digital therapeutic for adolescent depression

23andMe, moving beyond consumer DNA tests, is building a clinical trial recruitment business

23andMe and TrialSpark Announce Joint Clinical Trial Offering and Request For Proposals

TrialSpark debuts first clinical trial sites as part of deal with Novartis

Digital technologies hold the key to streamlining and improving clinical trials

TrialSpark licenses sprifermin from Merck & forms NewCo

After years of running trials for other drugmakers, TrialSpark is building its own pipeline

TrialSpark and Sanofi announce collaboration to accelerate COPD clinical development

Aditum Bio launches third company, Anteris Bio, in collaboration with TrialSpark

How do we get the data out as fast as possible so we can actually make a difference: TrialSpark CEO

Clinical trials could be hard hit by COVID-19, forcing some to adapt or close down

TrialSpark Bolsters Executive Team and Industry Experience with Two Key Hires

TrialSpark taps community clinics, doctors to increase clinical trial diversity

23andMe's new deal with TrialSpark looks to clinical trial recruitment

TrialSpark and Pfizer collaborating to improve speed and access to clinical trials

TrialSpark Joins Forces with Leading Global Healthcare Company to Work to Potentially Bring Novel Treatments to Patients Faster

TrialSpark hires two new executives to join company's leadership team

TrialSpark raises $156MM Series C led by Sam Altman & Lachy Groom

TrialSpark appoints Steven Holtzman as Sr. Advisor to the company

Understanding the real costs behind clinical trials: Exploring the primary cost drivers and strategies for improving trial efficiency

React, Adapt, Evolve: Clinical Trials During and Beyond COVID-19

The State of Digital Health in 2019 with Malay Gandhi and Nikhil Krishnan

Novartis-partnered TrialSpark pens 'digital' trial collab with Limbix

23andMe has inked a deal with TrialSpark to accelerate clinical research recruitment

23andMe, TrialSpark Partner on Clinical Trial Recruiting

Creating a new drug takes a decade and costs a fortune. Investors have poured almost $1 billion into startups trying to change that.

Reimagining Clinical Trials with Entrepreneur, Dr Ben Liu, CEO, Trialspark